Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 6, Issue 1
Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Commentary
Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
Online download statistics by month:
Online download statistics by month: December 2019 to February 2024
Abstract
Full
Pdf
Dec 2019
12
12
0
Jan 2020
72
72
2
Feb 2020
73
73
9
Mar 2020
77
77
20
Apr 2020
53
53
39
May 2020
77
77
40
Jun 2020
59
59
14
Jul 2020
90
90
16
Aug 2020
37
37
36
Sep 2020
52
52
22
Oct 2020
45
45
14
Nov 2020
50
50
13
Dec 2020
49
49
13
Jan 2021
56
55
13
Feb 2021
44
44
12
Mar 2021
55
55
20
Apr 2021
58
58
36
May 2021
49
49
37
Jun 2021
36
36
29
Jul 2021
45
45
28
Aug 2021
49
50
31
Sep 2021
66
66
44
Oct 2021
62
62
53
Nov 2021
71
71
52
Dec 2021
73
73
42
Jan 2022
51
53
20
Feb 2022
45
45
22
Mar 2022
42
44
20
Apr 2022
34
35
15
May 2022
67
69
22
Jun 2022
57
57
22
Jul 2022
52
55
16
Aug 2022
40
40
15
Sep 2022
43
45
24
Oct 2022
41
41
21
Nov 2022
31
34
27
Dec 2022
30
30
16
Jan 2023
60
60
21
Feb 2023
67
68
26
Mar 2023
83
84
29
Apr 2023
61
61
29
May 2023
69
69
16
Jun 2023
75
75
27
Jul 2023
73
74
25
Aug 2023
85
85
24
Sep 2023
57
58
14
Oct 2023
108
110
38
Nov 2023
114
116
24
Dec 2023
72
72
23
Jan 2024
29
31
15
Feb 2024
75
75
13
Total
2971
2996
1199
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?